Pharmaceutical Training Course Calendar

Back to details

Our Pharmaceutical calendar for the next 12 months:

Live online Classroom 2024 2025
May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr
A Practical Guide to Producing and Maintaining the PSMF Vigilance 5 10
A Practical Guide to Writing Risk Management Plans (RMPs) Vigilance 1 9
Advanced Pharmacovigilance Vigilance 5-7 18-20 9-13
Agile Leadership for Pharma and Biopharma Professionals in a hybrid world Leadership & Strategy 4-5 18-19
An Essential Overview of Medical Information Regulatory Affairs 11 29
An Essential Overview of Pharmacovigilance Vigilance 9-10
An Essential Overview of the Medical Device Industry Regulatory Affairs 8-9 8
An Essential Overview of the Pharmaceutical and Biotech Industries Regulatory Affairs 10 13
An Introduction to Human Factors for Pharmaceutical and Medical Device Professionals Regulatory Affairs 10 23
An Introduction to Pharmaceutical Packaging GxP 20-22 25-27
Best Practice for Writing Effective SOPs Regulatory Affairs 18 12
Best Practices for Supplier Qualification in Life Science GxP 15-16 27-28 27-28
Biosimilars Biopharma 10-11 1-2
Biotechnology for the Non-Biotechnologist Biopharma 24-28 25-27 2-6
CAPA (Corrective and Preventative Action) Regulatory Affairs 19 13
Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products GxP 27-28 17-18
Clinical Overview and Clinical Summary: Creating Effective Marketing Authorisation Application Regulatory Affairs 19-20 2-3
Clinical Quality Management Systems Clinical Research 23-24 19-20
Clinical Research - A Different Approach to Successful Project Delivery Clinical Research 10 4
Clinical Trial Monitoring Clinical Research 11-12 2-3
Clinical Trial Regulatory Requirements Clinical Research 2-3 16-17
Cognitive Testing in Clinical Drug Trials: Successful Test Selection and Integration Clinical Research 18
Consultative Selling for Pharma Professionals Sales 13-14 17-18
Cosmetovigilance Vigilance 20-21 14-15
Data Integrity Auditor Master Class GxP 24-25 16-17
Data Integrity and Document Management GxP 22 6
Delivery of Biologics to the Nasal Cavity Biopharma 4 8
Development of Combination Products: Critical Interactions GxP 25-26 3-4
Drafting Commercial Contracts for the Pharmaceutical Industry Commercial Contracts 8-9 20-21
Drafting and Negotiating Clinical Trial Agreements Commercial Contracts 5
Drug Discovery: A Step-by-Step Introduction Medical Technology 23-24
EU Clinical Trial Regulation 536/2014: Overview and Implementation Experience Clinical Research 20-21 25-26 11-12
EU Pharmaceutical Regulations & Strategy Regulatory Affairs 10-11 14-15
EU Proposed Pharmaceutical Legislation Changes Regulatory Affairs 22 18
Effective Technical Writing & Editing Medical Writing 28 1
Effective Technology Transfer GxP 16-17 7-8
Effective Training Skills in the Pharma Industry Coaching & Mentoring 13-14 10-11
European Post Marketing Pharmacovigilance - Including the EMA/PRAC Deliberations and Brexit Implications Vigilance 15-17 4-8
GCP and Clinical Research Update - Hot Inspection Topics Clinical Research 1 22
Global Pharmaceutical Regulatory Affairs Summer School Regulatory Affairs 10-14
Good Distribution Practices of Pharmaceuticals and APIs GxP 22-23 14-15 17-18
ICH Q9(R1) Quality Risk Management (QRM) GxP 1 25
MBA Strategic Thinking for Pharma and Biopharma Professionals Leadership & Strategy 15-16 3-4
Managing Service Providers including CRO and CMOs oversight to comply with ICH GCP R3 Clinical Research 24-25 17-18
Metrics and Earned Value in Clinical Research Projects Clinical Research 11 25
New EU GMP Annex 1: Compliant Aseptic Operations GxP 2-4 26-28
Pharmaceutical Development of ATMPs GxP 18-19 14-15
Pharmaceutical Regulatory Affairs in Africa Regulatory Affairs 17-18 19-22
Pharmaceutical Regulatory Affairs in Asia Regulatory Affairs 12-14 9-11
Pharmaceutical Regulatory Affairs in China Regulatory Affairs 2-3 10-11
Pharmaceutical Regulatory Affairs in Latin America Regulatory Affairs 19 22 25
Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union Regulatory Affairs 24-25 3-4
Pharmaceutical Regulatory Affairs in the Middle East Regulatory Affairs 26-27 9-10
Pharmacovigilance Aspects of Licensing Agreements Vigilance 10 27-28
Pharmacovigilance QMS & Inspection Preparation Vigilance 20-21 26-27
Pharmacovigilance for Drug Safety, Regulatory Affairs and PV Auditors - Broadening your Knowledge Vigilance 30-2
Positive Persuading and Influencing Skills for Pharma Professionals Management 29-30 11-12
Practical Requirements of the Arab Pharmacovigilance Guidelines Vigilance 13-14 17-18
Process Validation with Qualification GxP 21-22 23-24
Project Management for Pharma Professionals Project Management 17-18 26-27 9-10
Regulatory Affairs for Support Staff Regulatory Affairs 24-25
Regulatory Strategies for Orphan Drugs Regulatory Affairs 24 8
Risk Management for Pharma and Biopharma Professionals Regulatory Affairs 7 8
Root Cause Analysis and Critical Thinking Management 23 25
Signal Detection and Regulatory Expectations Vigilance 1-2 12-15
Smart Packaging and Electronic Patient Information GxP 10 4-5
Stability Testing of Pharmaceuticals and Biopharmaceuticals GxP 11-12 11-12
Successful Medical Writing – from Protocol to CTD Medical Writing 27-29
The Common Technical Document GxP 8-9 25-26
The Common Technical Document (CTD) Submission in the MENA Region Regulatory Affairs 10 28
The FDA Drug Approval Process Regulatory Affairs 12-13 2-3
The Leadership and Management Summer School for Pharma Professionals Leadership & Strategy 29-2
The Pharma Mini MBA Leadership & Strategy 15-17 31-2 6-8
US FDA - Understanding Key Factors When Working with the FDA Biopharma 12 27
Understanding Active Pharmaceutical Ingredients (APIs) GxP 17-18 18-19
Understanding Computer System Validation (CSV) GxP 24-25 25-26
Understanding Pharmacovigilance Regulations in APAC Vigilance 8-9 8-9
Understanding and Interpreting the Proposed Changes to EU GMP Annex 11 GxP 17 21
Variations to Marketing Authorisations Regulatory Affairs 10-11 28-29
Working with Emotional Intelligence in the Pharmaceutical and Biopharma Industry Leadership & Strategy 21 14